mySmartSkin for the Improvement of Skin Self-Examination in Melanoma Survivors

PRIMARY OBJECTIVES:

I. To enhance mySmartSkin (MSS) by collaborating with multi-level stakeholders.

II. To evaluate the effects of enhanced MSS on thorough skin self-examination (SSE) in an randomized controlled trial (RCT) and examine its impact on the diagnosis of new/recurrent melanomas (N= 300).

III. To assess selected implementation outcomes and identify factors relevant to future scale-up for widespread dissemination and implementation.

IIIa.To estimate program costs and assess cost-effectiveness of MSS relative to control.

IIIb. To examine MSS’ reach, adoption, engagement, acceptability, appropriateness, feasibility, and maintenance.

IIIc. To identify and describe contextual factors from multilevel stakeholders as key to scale-up and widespread implementation of MSS, including consideration of potential delivery settings, timing of delivery, and needed resources to promote its implementation and sustainability.

OUTLINE:

AIM I (MSS Enhancement): Patients take part in key informant interviews.

AIM II: Participants are randomized to 1 of 2 arms

ARM I (Educational webpage): Patients view on-interactive educational webpage and complete surveys on study.

ARM II (comparison): Patients take part in key informant interviews on study.

AIM III: Patients complete surveys and take part in interviews.